fibrin and Retinal-Neovascularization

fibrin has been researched along with Retinal-Neovascularization* in 3 studies

Other Studies

3 other study(ies) available for fibrin and Retinal-Neovascularization

ArticleYear
Abscisic acid - an anti-angiogenic phytohormone that modulates the phenotypical plasticity of endothelial cells and macrophages.
    Journal of cell science, 2018, 02-02, Volume: 131, Issue:3

    Abscisic acid (ABA) has shown anti-inflammatory and immunoregulatory properties in preclinical models of diabetes and inflammation. Herein, we studied the effects of ABA on angiogenesis, a strictly controlled process that, when dysregulated, leads to severe angiogenic disorders including vascular overgrowth, exudation, cellular inflammation and organ dysfunction. By using a 3D sprouting assay, we show that ABA effectively inhibits migration, growth and expansion of endothelial tubes without affecting cell viability. Analyses of the retinal vasculature in developing normoxic and hyperoxic mice challenged by oxygen toxicity reveal that exogenously administered ABA stunts the development and regeneration of blood vessels. In these models, ABA downregulates endothelial cell (EC)-specific growth and migratory genes, interferes with tip and stalk cell specification, and hinders the function of filopodial protrusions required for precise guidance of vascular sprouts. In addition, ABA skews macrophage polarization towards the M1 phenotype characterized by anti-angiogenic marker expression. In accordance with this, ABA treatment accelerates macrophage-induced programmed regression of fetal blood vessels. These findings reveal protective functions of ABA against neovascular growth through modulation of EC and macrophage plasticity, suggesting the potential utility of ABA as a treatment in vasoproliferative diseases.

    Topics: Abscisic Acid; Animals; Animals, Newborn; Cell Differentiation; Cell Movement; Cell Plasticity; Cell Proliferation; Endothelial Cells; Fetus; Fibrin; Gels; Macrophage Activation; Macrophages; Mice; Models, Biological; Neovascularization, Physiologic; Phenotype; Plant Growth Regulators; Retina; Retinal Neovascularization

2018
A novel ex vivo murine retina angiogenesis (EMRA) assay.
    Experimental eye research, 2013, Volume: 112

    Pathological retinal angiogenesis results from the imbalance of pro-angiogenic and anti-angiogenic factors. In particular, vascular endothelial growth factor (VEGF) plays a pivotal role in retinal neovascularization and various therapeutic VEGF blockers have evolved over time. Nevertheless, new retinal angiogenesis models are crucial for investigating anti-angiogenic therapies and bringing them to patients. Here, we developed a novel ex vivo murine retina angiogenesis (EMRA) assay in which endothelial sprouts originate from mature and quiescent retinal vessels. In this model, retina fragments from adult mice are embedded in a three-dimensional fibrin gel in the presence of human recombinant VEGF. Starting from the 3rd-4th day of incubation, endothelial cell sprouts invading the fibrin gel can be observed under an inverted microscope and measured at different time points thereafter. The effect of VEGF is dose-dependent, maximal stimulation being observed at day 7 for retina fragments stimulated with 25-75 ng/ml of the growth factor. To assess whether the EMRA assay is suitable for testing the activity of anti-angiogenic compounds, retina fragments were incubated with VEGF in the presence of the neutralizing anti-VEGF antibodies bevacizumab and ranibizumab. The results demonstrate that both antibodies inhibit VEGF activity in a dose-dependent manner. In conclusion, the EMRA assay represents a new ex vivo model of retinal neovascularization suitable for the rapid screening of novel anti-angiogenic therapeutics.

    Topics: Angiogenesis Inhibitors; Animals; Antibodies, Monoclonal, Humanized; Antibodies, Neutralizing; Bevacizumab; Biological Assay; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Fibrin; Mice; Mice, Inbred C57BL; Organ Culture Techniques; Ranibizumab; Recombinant Proteins; Retina; Retinal Neovascularization; Retinal Vessels; Vascular Endothelial Growth Factor A

2013
Pathologic features of surgically excised subretinal neovascular membranes in age-related macular degeneration.
    American journal of ophthalmology, 1991, Dec-15, Volume: 112, Issue:6

    The histopathologic features of ten consecutive surgically excised subfoveal neovascular membranes from patients with age-related macular degeneration were examined. Ultrastructural features included the following in decreasing order of frequency: endothelium-lined vascular channels, new collagen, fibrocytes, retinal pigment epithelium, erythrocytes, and myofibroblasts. Chronic inflammatory cells were frequently evident and included macrophages, lymphocytes, and plasma cells. Basal laminar deposit or diffuse drusen were observed in six of the membranes. Photoreceptors and Bruch's membrane were each observed in three of the specimens, but were not associated with decreased postoperative visual acuity. Fibrin was observed in eight membranes, either within the stroma of the membrane or in association with subretinal hemorrhage.

    Topics: Age Factors; Collagen; Endothelium, Vascular; Fibrin; Fibroblasts; Humans; Macrophages; Macular Degeneration; Pigment Epithelium of Eye; Retinal Neovascularization

1991